文献速递肝病消化道肿瘤与早癌

转化生长因子-β与Axl诱导肝细胞癌中CXCL5表达及中性粒细胞募集

Transforming Growth Factor-β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma.
PubMed 文献 · Hepatology · 2018-12-20

研究利用两种对TGF-β反应表型相反的人肝细胞癌模型,发现TGF-β与Axl信号协同诱导趋化因子CXCL5表达与分泌,进而吸引中性粒细胞;小鼠移植瘤形成依赖CXCL5,患者中Axl与CXCL5高表达与晚期肿瘤、中性粒细胞浸润及生存期缩短相关。

要点

  • TGF-β与Axl信号协同诱导肝细胞癌CXCL5表达和分泌。
  • CXCL5介导中性粒细胞向肝细胞癌组织募集。
  • 患者中Axl与CXCL5高表达与晚期肿瘤及生存期缩短相关。

核心结论

  • TGF-β与Axl协同诱导CXCL5分泌,导致中性粒细胞浸润肝细胞癌组织;干预TGF-β/Axl/CXCL5信号可能是对抗TGF-β阳性患者肝细胞癌进展的有效治疗策略。

研究设计与样本

  • 研究分析两种对TGF-β反应表型相反的人肝细胞癌细胞模型,并进行转录组分析、小鼠移植瘤实验及患者组织分析。

主要发现

  • 两种肝细胞癌模型在TGF-β刺激后均表现为增殖和克隆形成能力降低,但在化疗敏感性和迁移能力上存在差异。
  • 转录组分析显示趋化因子CXCL5受到差异调控,且CXCL5在肝细胞癌患者中与TGF-β表达呈正相关。
  • CXCL5的表达和分泌依赖Axl表达,提示CXCL5是TGF-β靶基因并与Axl信号协同。
  • 缺失TGF-β或Axl信号均可消除CXCL5依赖的中性粒细胞吸引作用。
  • 小鼠中移植的肝细胞癌细胞成瘤依赖CXCL5表达;患者中Axl和CXCL5高表达与晚期肿瘤分期、中性粒细胞浸润肝细胞癌组织及生存期缩短相关。

临床怎么用

  • 作者认为,干预TGF-β/Axl/CXCL5信号可能是对抗TGF-β阳性患者肝细胞癌进展的有效治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Transforming growth factor (TGF)-β suppresses early hepatocellular carcinoma (HCC) development but triggers pro-oncogenic abilities at later stages. Recent data suggest that the receptor tyrosine kinase Axl causes a TGF-β switch toward dedifferentiation and invasion of HCC cells. Here, we analyzed two human cellular HCC models with opposing phenotypes in response to TGF-β. Both HCC models showed reduced proliferation and clonogenic growth behavior following TGF-β stimulation, although they exhibited differences in chemosensitivity and migratory abilities, suggesting that HCC cells evade traits of anti-oncogenic TGF-β. Transcriptome profiling revealed differential regulation of the chemokine CXCL5, which positively correlated with TGF-β expression in HCC patients. The expression and secretion of CXCL5 was dependent on Axl expression, suggesting that CXCL5 is a TGF-β target gene collaborating with Axl signaling. Loss of either TGF-β or Axl signaling abrogated CXCL5-dependent attraction of neutrophils. In mice, tumor formation of transplanted HCC cells relied on CXCL5 expression. In HCC patients, high levels of Axl and CXCL5 correlated with advanced tumor stages, recruitment of neutrophils into HCC tissue, and reduced survival. Conclusion: The synergy of TGF-β and Axl induces CXCL5 secretion, causing the infiltration of neutrophils into HCC tissue. Intervention with TGF-β/Axl/CXCL5 signaling may be an effective therapeutic strategy to combat HCC progression in TGF-β-positive patients.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Haider C, Hnat J, Wagner R, et al. Transforming Growth Factor-β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma. Hepatology. 2018. PMID: 30014484. doi:10.1002/hep.30166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。